From Molecules to Medicine: New Horizons in Vascular Biology and Thrombosis (Part II)

Thromb Haemost 2008; 99(03): 465
DOI: 10.1160/TH08-02-0070

Theme Issue Editorial

Schattauer GmbH

Klaus T. Preissner^*

¹Institute for Biochemistry, Medical School, Justus-Liebig-University, Giessen, Germany

References
1 Gachet C. P2 receptors, platelet function and pharmacological implications. Thromb Haemost 2008; 99: 466-472.
2 Clemetson K, Clemetson J. Platelet GPIb complex as a target for anti-thrombotic drug development. Thromb Haemost 2008; 99: 473-479.
3 Langer H, Gawaz M. Platelet-vessel wall interactions in atherosclerotic disease. Thromb Haemost 2008; 99: 480-486.
4 May AE, Geisler T, Gawaz M. Individualized antithrombotic therapy in high risk patients after coronary stenting. Thromb Haemost 2008; 99: 487-493.
5 Wygrecka M, Jablonska E, Guenther A. et al. Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases. Thromb Haemost 2008; 99: 494-501.
6 Alessi MC, Juhan-Vague I. Metabolic syndrome, haemostasis and thrombosis. Thromb Haemost. 2008 99. to be published in the April issue.